Enhanced sulfate pseudo-affinity chromatography using monolith-like particle architecture for purifying SARS-CoV-2. Kadoi K, Toba J, Uehara A, Isoda N, et al. Vaccine 2025;53:126951.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kadoi K, Toba J, Uehara A, Isoda N, et al. Enhanced sulfate pseudo-affinity chromatography using monolith-like particle architecture for purifying SARS-CoV-2. Vaccine 2025;53:126951.
PMID: 40037125